Recombinant CD19 (Tafasitamab Biosimilar) antibody

Catalog No. ABIN7828991

The Humanized Monoclonal anti-CD19 (Tafasitamab Biosimilar) antibody is suitable to detect CD19 (Tafasitamab Biosimilar) in samples from Human. It has been validated for ELISA.

Quick Overview for Recombinant CD19 (Tafasitamab Biosimilar) antibody (ABIN7828991)

Target: CD19 (Tafasitamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD19 (Tafasitamab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-CD19 (Tafasitamab Biosimilar) Antibody

Purpose: Anti-CD19(tafasitamab biosimilar) mAb

Isotype: IgG1, IgG2, kappa

Application Details

Application Notes: ELISA 1:5000-10000

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CD19 (Tafasitamab Biosimilar)

Target: CD19 (Tafasitamab Biosimilar)

Alternative Name: Tafasitamab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CD19,B4,CVID3,MGC12802
Synonyms Antibody:MOR208, XmAb5574, XmAb®5574, MOR-00208, MOR-208, XENP-5574, XMP-5574, XmAb-5574, Xmab-CD19, Xmab5574, tafasitamab-cxix

UniProt: P15391